Farabi Pharmaceutical Company (DFARA) income statement
Operating revenue through to net profit and earnings per share
- Ticker
- DFARA
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/06/31 | To 1401/06/31 | To 1400/06/31 |
|---|---|---|---|---|---|---|
| Operating revenue | 39,911,022 | 17,927,528 | 13,370,685 | 11,454,278 | 4,456,189 | 2,903,890 |
| Cost of operating revenue | -17,948,060 | -12,600,523 | -9,528,219 | -7,790,765 | -3,143,021 | -2,184,277 |
| Gross profit (loss) | 21,962,962 | 5,327,005 | 3,842,466 | 3,663,513 | 1,313,168 | 719,613 |
| Selling, general and administrative expenses | -765,457 | -978,670 | -532,000 | -505,998 | -216,446 | -181,661 |
| Other expenses | -78,968 | -73,028 | -91,217 | -36,382 | 0 | -13,522 |
| Operating profit (loss) | 21,118,537 | 4,400,919 | 3,219,261 | 3,121,133 | 1,096,722 | 524,430 |
| Finance costs | -744,701 | -967,836 | -744,323 | -272,964 | -617,054 | -252,179 |
| Other non-operating income and expenses | 18,004 | 65,021 | 115,875 | 114,591 | 18,734 | 4,813 |
| Profit (loss) from continuing operations before tax | 20,391,840 | 3,498,104 | 2,590,813 | 2,962,760 | 498,402 | 277,064 |
| Current year tax | -4,050,874 | -691,395 | -525,749 | -573,077 | -99,155 | -94,699 |
| Net profit (loss) from continuing operations | 16,340,966 | 2,806,709 | 2,065,064 | 2,389,683 | 399,247 | 182,365 |
| Net profit (loss) | 16,340,966 | 2,806,709 | 2,065,064 | 2,389,683 | 399,247 | 182,365 |
| Basic earnings (loss) per share | 1,778 rials | 305 rials | 1,293 rials | 1,496 rials | 250 rials | 305 rials |
| Net earnings (loss) per share, rials | 1,776 rials | 305 rials | 1,291 rials | 1,494 rials | 250 rials | 114 rials |
| Capital | 9,206,000 | 9,206,000 | 1,600,000 | 1,600,000 | 1,600,000 | 1,600,000 |
Reporting periods
91 periods are on file for this report, from the period ending 1380/12/29 to the period ending 1405/06/31.